Trump White House erases, silences HIV, LGBTQ and health content
Trump’s numerous attacks on diversity, equity and inclusion (DEI) efforts have led federal agencies to strip their web pages of content focused on diversity. Of note, the Food and Drug Administration (FDA) removed web pages referencing ethnic and economic diversity in clinical trials, reports STAT News. Anti-diversity efforts in clinical trials could result in the approval of drugs that do not work for the population at large, since the effects of medications may vary depending on age, sex and other factors.
STAT reported that it found 10 examples of pages related to diversity and equity that were removed from the FDA website, including draft guidance on clinical trial diversity and a slide deck on boosting enrollment in cancer clinical trials. STAT noted that the removals seemed “haphazard” and that some pages related to DEI efforts remained up.
Read the full story at POZ.
SEE ALSO:
- Science: Trump’s ban on funds to ‘promote gender ideology’ could threaten hundreds of NIH research projects /24 January 2025/
- Health Policy Watch: Trump administration halts health communications, freezes research grants /24 January 2025/
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.